Published in Medical Letter on the CDC and FDA, December 22nd, 1997
AZT is an anti-retroviral drug designed by Glaxo Wellcome to prevent the onset of AIDS in people with HIV.
"The Thailand trials will be completed in early January. The results will be out a couple of months later after follow-up work," said Stefan Wiktor, who leads AIDS research in Ivory Coast for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.